RET fusion-positive NSCLC patients benefit from targeted therapies like Retevmo and Gavreto, recommended by NCCN guidelines for first-line treatment. Gavreto demonstrated a 57% overall response rate ...
March 20, 2009 (Hollywood, Florida) — In ovarian cancer patients who have been optimally debulked through surgery, a peritoneal catheter should be considered in the administration of subsequent ...
PLYMOUTH MEETING, PA [October 6, 2025] — Today, the National Comprehensive Cancer Network ® (NCCN ®)—a nonprofit responsible for globally utilized guidelines for cancer care—is sharing new NCCN ...
Free information from the National Comprehensive Cancer Network offers information on how and why to access genetic counseling and testing for multiple hereditary cancers “No other landscape in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback